Business
SETi and Psoria-Shield, Inc. Enter Into Agreement to Commercialize Psoria-Light System and Expand Adoption for UVB Phototherapy
SETi and Psoria-Shield, Inc. Enter Into Agreement to Commercialize Psoria-Light System and Expand Adoption for UVB Phototherapy.
About this update from Wellness Center Usa Inc
[{"type":"text","content":"\n \n \n SETi and Psoria-Shield, Inc. Enter Into Agreement to Commercialize Psoria-Light System and Expand Adoption for UVB Phototherapy\n \n \nSETi and Psoria-Shield, Inc. Enter Into Agreement to Commercialize Psoria-Light System and Expand Adoption for UVB Phototherapy\n \n COLUMBIA, SC--(Marketwired - Dec 4, 2015) - Sensor Electronic Technology, Inc. (SETi), a world leader in UVB and UVC LEDs, has signed a long term agreement with Psoria-Shield, Inc. (PSI), a wholly-owned subsidiary of Wellness Center USA, Inc. (OTCQB: WCUI), to further develop the UV LED light source used exclusively in the Psoria-Light® (PL 1000) system manufactured and sold by PSI. The development is fundamentally based on increasing performance and reducing unit cost.\n SETi plans to integrate its new high performance (308 nm) LED manufacturing process that emits up to 2mW of UVB power at 20mA drive current in a new high power light source delivering over 400mW of optical power. This performance and associated price/performance improvements make SETi LEDs a compelling solution for UVB dermatology treatments.\n PSI is an advanced phototherapy company that has developed, manufactures, and distributes the Psoria-Light phototherapy system. The PL 1000 uses targeted high dosage UV LEDs with both cost and safety benefits to that of a conventional excimer laser. The result is an FDA cleared, highly effective system that is simple to use and requires no special laser room, no laser certification or special operator qualifications. \n \"A major advantage of our LED based technology is its solid state reliability and reduced maintenance coupled with it being a class 2 product, which does not require a physician to clinically provide the treatment. It can be delivered by office staff and be in compliance with existing billing codes. This allows offices and doctors to be more efficient,\" stated John Yorke, Managing Director of Psoria Development Corp (PDC). \"We believe the treatment and use of UVB LEDs will become the industry standard. The PL 1000 is highly portable and can be moved from room to room, with no special power requirements,\" Yorke added. \n Emmanuel Lakios, President and CEO of SETi, added \"Similar improvements have been made to power, lifetime and price/performance to our other 230nm to 340nm LED wavelengths. Of partic...